단계 미표기초청 등록
A Two-year Prospective, Observational Study of Wegovy in Real-world Clinical Practice
연구 개요
This observational study will explore how Wegovy® (Semaglutide) is used in everyday situations, how it might affect things like weight, body mass index (BMI) and waist circumference, and what kind of impact it could have on overall quality of life. The overall purpose of this study is to understand how Wegovy impacts weight when used as part of regular medical care. Participants will be treated with Wegovy as prescribed to the participant by their doctor, in accordance with normal clinical practice. The study will last for about two years.
- 스폰서
- 리드: 노보노디스크
- 적응증
- Obesity
- 중재
- Semaglutide
- 목표 등록
- 1,250명
- 시작일
- 2025-05-01
- 완료(예정)
- 2028-08-15
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.